Literature DB >> 17191121

NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells.

J H Lim1, J-W Park, D S Min, J-S Chang, Y H Lee, Y B Park, K S Choi, T K Kwon.   

Abstract

Quercetin, a flavonoid molecule ubiquitously present in nature, has multiple effects on cancer cells, including the inhibition of cell proliferation and migration. However, the responsible molecular mechanisms are not fully understood. We found that quercetin induces the expression of NAG-1 (Non-steroidal anti-inflammatory drug activated gene-1), a TGF-beta superfamily protein, during quercetin-induced apoptosis of HCT116 human colon carcinoma cells. Reporter assays using the luciferase constructs containing NAG-1 promoter region demonstrate that early growth response-1 (EGR-1) and p53 are required for quercetin-mediated activation of the NAG-1 promoter. Overexpression of NAG-1 enhanced the apoptotic effect of quercetin, but suppression of quercetin-induced NAG-1 expression by NAG-1 siRNA attenuated quercetin-induced apoptosis in HCT116 cells. Taken together, the present study demonstrates for the first time that quercetin induces apoptosis via NAG-1, providing a mechanistic basis for the apoptotic effect of quercetin in colon carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17191121     DOI: 10.1007/s10495-006-0576-9

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  28 in total

1.  NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer.

Authors:  Vivek Vaish; Honit Piplani; Chandan Rana; Kim Vaiphei; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2013-02-23       Impact factor: 3.396

2.  Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.

Authors:  Lynne M Howells; Robert G Britton; Marco Mazzoletti; Peter Greaves; Massimo Broggini; Karen Brown; William P Steward; Andreas J Gescher; Stewart Sale
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

3.  The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.

Authors:  Xingya Wang; Philip J Kingsley; Larry J Marnett; Thomas E Eling
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

Review 4.  Friend or foe, the role of EGR-1 in cancer.

Authors:  Tong-Tong Li; Man-Ru Liu; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2019-11-20       Impact factor: 3.064

Review 5.  Growth differentiation factor 15 in erythroid health and disease.

Authors:  Toshihiko Tanno; Pierre Noel; Jeffery L Miller
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

6.  CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract.

Authors:  Carlota Oleaga; Miriam García; Anna Solé; Carlos J Ciudad; Maria Izquierdo-Pulido; Véronique Noé
Journal:  Eur J Nutr       Date:  2011-08-06       Impact factor: 5.614

7.  Serum cytokine concentrations, flavonol intake and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  G Bobe; G Murphy; P S Albert; L B Sansbury; E Lanza; A Schatzkin; N H Colburn; A J Cross
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

8.  FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.

Authors:  Igor Shats; Michael L Gatza; Beiyu Liu; Steven P Angus; Lingchong You; Joseph R Nevins
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

Review 9.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

10.  Induction of apoptosis and nonsteroidal anti-inflammatory drug-activated gene 1 in pancreatic cancer cells by a glycyrrhetinic acid derivative.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Sudhakar Chintharlapalli; Sabitha Papineni; Stephen Safe
Journal:  Mol Carcinog       Date:  2009-08       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.